Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by RogueGeekon Jul 10, 2018 11:19am
89 Views
Post# 28293084

RE:RE:RE:Facts for the idiots who are bashing

RE:RE:RE:Facts for the idiots who are bashingOk then post your facts. So far all you have said is basicly "booo kaly" without giving a single reason. That seems a lot like trash talk to me. Maybe come up with some something factual that people can verify. I'm going to guess your responce, if there is one, will be something along the lines of "do you own DD". You must not have much of a life if you can constantly blog about a stock you dislike on a website that is as usless as foreskin. 

Number27 wrote: Keep pumping, I was once in your shoes too. 

I'd like to rephrase. Management team, not Kaly shareholders have money now. Just be clear.

Days like the past several years have been great for buying according to you. At what point does one start selling a profit? You must have money coming from all angles. 

FDA is not a catalyst to move prices up. Where have you been?? The FDA just granted it's first marijuana drug and the price went down. 

Again, stop preaching false information. 

 


Bullboard Posts